Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset - HMS LINCS Database

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)

Download: Excel (XLSX), Comma-separated (CSV)

<<<<

Select the entities to show:

Small molecules	Cells	Antibodies

|<
<<
Previous
Page 1050 of 3330
Next
>>
>
26226 to 26250 of 83232 records
per page:

Cell	Clinical Subtype	Transcriptional Subtype	Small Molecule	Perturbagen Target	Perturbagen Class	Perturbagen Concentration	Perturbagen Conc Unit	Biological Replicate ID	Relative Cell Count	Normalized Growth Rate Inhibition Value	Nominal Division Rate
600MPE	HR+	Luminal	FR180204	ERK1/2	MAPK	100	uM	12224.161	0.4614	-0.3232	0.7139
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.0000853	uM	10880.149	0.9008	0.8758	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.000427	uM	10880.149	0.9964	0.9956	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.00213	uM	10880.149	0.9350	0.9192	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.0107	uM	10880.149	0.9356	0.9199	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.0533	uM	10880.149	0.9762	0.9707	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	0.267	uM	10880.149	0.9235	0.9046	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	1.33	uM	10880.149	0.9428	0.9290	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	6.67	uM	10880.149	0.8946	0.8678	1.6289
AU565	HER2amp	Luminal	FR180204	ERK1/2	MAPK	33.3	uM	10880.149	0.9088	0.8860	1.6289
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.0000853	uM	10581.137	0.9486	0.9138	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.000427	uM	10581.137	0.9121	0.8520	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.00213	uM	10581.137	1.0006	1.0010	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.0107	uM	10581.137	0.9382	0.8962	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.0533	uM	10581.137	1.0256	1.0427	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.267	uM	10581.137	0.9965	0.9942	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	1.33	uM	10581.137	0.9253	0.8744	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	6.67	uM	10581.137	0.9478	0.9124	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	33.3	uM	10581.137	0.8205	0.6954	1.1975
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.000256	uM	11854.161	0.9279	0.8800	1.2085
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.00128	uM	11854.161	0.9498	0.9166	1.2085
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.0064	uM	11854.161	1.0093	1.0153	1.2085
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.032	uM	11854.161	0.9566	0.9279	1.2085
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.16	uM	11854.161	0.9584	0.9310	1.2085
BT-20	TNBC	Basal A	FR180204	ERK1/2	MAPK	0.8	uM	11854.161	0.9375	0.8961	1.2085

|<
<<
Previous
Page 1050 of 3330
Next
>>
>
26226 to 26250 of 83232 records
per page:

HMS LINCS Project

Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 1 of 4: Relative cell counts and normalized growth rate inhibition values across technical replicates. - Dataset (ID:20268)